Research and treatment approaches to depression (original) (raw)

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, Washington, DC, 1994).
• Zis, A. P. & Goodwin, F. K. Major affective disorder as a recurrent illness: a critical review. Arch. Gen. Psychiatry 36, 835–839 (1979).
  CAS PubMed Google Scholar
• Sundstrom, I. M., Bixo, M., Bjorn, I. & Astrom, M. Prevalence of psychiatric disorders in gynecologic outpatients. Am. J. Obstet. Gynecol. 184, 8–13 (2001).
  CAS PubMed Google Scholar
• Lyness, J. M., Caine, E. D., King, D. A., Cox, C. & Yoediono, Z. Psychiatric disorders in older primary care patients. J. Gen. Intern. Med. 14, 249–254 (1999).
  CAS PubMed PubMed Central Google Scholar
• Lindeman, S. et al. The 12-month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults. Acta Psychiatr. Scand. 102, 178–184 (2000).
  CAS PubMed Google Scholar
• Dubini, A., Mannheimer, R. & Pancheri, P. Depression in the community: results of the first Italian survey. Int. Clin. Psychopharmacol. 16, 49–53 (2001).
  CAS PubMed Google Scholar
• Fichter, M. M. et al. Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program. J. Nerv. Ment. Dis. 184, 598– 606 (1996).
  CAS PubMed Google Scholar
• Tomoda, A., Mori, K., Kimura, M., Takahashi, T. & Kitamura, T. One-year prevalence and incidence of depression among first-year university students in Japan: a preliminary study. Psychiatry Clin. Neurosci. 54, 583– 588 (2000).
  CAS PubMed Google Scholar
• Weissman, M. M. et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276, 293– 299 (1996).A detailed assessment of lifetime and annual rate depression prevalence in ten countries: Canada, France, Germany, Italy, Korea, Lebanon, New Zealand, Puerto Rico, Taiwan and the United States.
  CAS PubMed Google Scholar
• Blazer, D. G., Kessler, R. C., McGonagle, K. A. & Swartz, M.S. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry 151, 979–986 (1994).
  CAS PubMed Google Scholar
• Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N. & Berndt, E. R. The economic burden of depression in 1990. J. Clin. Psychiatry 54, 405–418 ( 1993).Estimates that the total cost of depression in the United States was $43.7 billion per year in 1990.
  CAS PubMed Google Scholar
• Murray, C. J. L. & Lopez, A. D. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk factors in 1990 and Projected to 2020 (Harvard Univ. Press, Cambridge, Massachusetts, 1996).
  Google Scholar
• Murphy, S. L. Deaths: Final data for 1998. Natl Vital Stat Rep 48 , 1–105 (2000).
  CAS PubMed Google Scholar
• Olsson, G. I. & von Knorring, A. L. Adolescent depression: prevalence in Swedish high-school students. Acta Psychiatr. Scand. 99, 324–331 (1999).
  CAS PubMed Google Scholar
• Klerman, G. L. in The Harvard Guide to Modern Psychiatry (ed. Nicholi, J.) 253–281 (Belknap/Harvard Univ. Press, Cambridge, 1978).
  Google Scholar
• Kerr, T. A., Schapira, K. & Roth, M. The relationship between premature death and affective disorders. Br. J. Psychiatry 115, 1277– 1282 (1969).
  CAS PubMed Google Scholar
• Harris, E. C. & Barraclough, B. Excess mortality of mental disorder . Br. J. Psychiatry 173, 11– 53 (1998).
  CAS PubMed Google Scholar
• Pratt, L. A. et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 94, 3123–3129 (1996).
  CAS PubMed Google Scholar
• Glassman, A. H. & Shapiro, P. A. Depression and the course of coronary artery disease. Am. J. Psychiatry 155, 4–11 (1998). References 18 and 19 report that a history of depression increases the risk of myocardial infarction and the risk of death after infarction.
  CAS PubMed Google Scholar
• Michelson, D. et al. Bone mineral density in women with depression. N. Engl. J. Med. 335, 1176–1181 (1996).
  CAS PubMed Google Scholar
• Agid, O. et al. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol. Psychiatry 4, 163 –172 (1999).Shows that loss of a parent (mother more than father) before age nine is a significant predictor of depression later in life.
  CAS PubMed Google Scholar
• Nemeroff, C. B. The preeminent role of early untoward experience on vulnerability to major psychiatric disorders: the nature–nurture controversy revisited and soon to be resolved. Mol. Psychiatry 4, 106–108 (1999).
  CAS PubMed Google Scholar
• Lewis, A. J. Melancholia: a clinical survey of depressive states. Natl Vital Stat Rep 80, 277–378 ( 1934).A classic description of depression.
  Google Scholar
• Garside, R. F., Kay, D. W., Wilson, I. C., Deaton, I. D. & Roth, M. Depressive syndromes and the classification of patients. Psychol. Med. 1, 333– 338 (1971).
  CAS PubMed Google Scholar
• Gurland, B. Aims, organization, and initial studies of the Cross-National Project. Int. J. Aging Hum. Dev. 7, 283–293 (1976).
  CAS PubMed Google Scholar
• Katz, M. M., Secunda, S. K., Hirschfeld, R. M. & Koslow, S. H. NIMH clinical research branch collaborative program on the psychobiology of depression. Arch. Gen. Psychiatry 36, 765 –771 (1979).
  CAS PubMed Google Scholar
• World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnosis Guidelines (World Health Organization, Geneva, Switzerland, 1992 ).
• Akiskal, H. S. Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin . J. Affect. Disord. 62, 17– 31 (2001).
  CAS PubMed Google Scholar
• Seligman, M. E. Learned helplessness as a model of depression. Comment and integration. J. Abnorm. Psychol. 87, 165–179 (1978).
  CAS PubMed Google Scholar
• Seligman, M. E., Maier, S. F. & Geer, J. H. Alleviation of learned helplessness in the dog. J. Abnorm. Psychol. 73, 256–262 (1968).
  CAS PubMed Google Scholar
• Seligman, M. E., Rosellini, R. A. & Kozak, M. J. Learned helplessness in the rat: time course, immunization, and reversibility. J. Comp. Physiol. Psychol. 88, 542–547 (1975).
  CAS PubMed Google Scholar
• Kalin, N. H. & Carnes, M. Biological correlates of attachment bond disruption in humans and nonhuman primates. Prog. Neuropsychopharmacol. Biol. Psychiatry 8, 459–469 (1984).
  CAS PubMed Google Scholar
• Plotsky, P. M. & Meaney, M. J. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res. Mol. Brain Res. 18, 195– 200 (1993).
  CAS PubMed Google Scholar
• Blanchard, D. C. & Blanchard, R. J. Behavioral correlates of chronic dominance-subordination relationships of male rats in a seminatural situation. Neurosci. Biobehav. Rev. 14 , 455–462 (1990). References 29 – 34 examine animal syndromes that model aspects of the depression phenotype.
  CAS PubMed Google Scholar
• Weissman, M. M. et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am. J. Psychiatry 136, 555–558 (1979).
  CAS PubMed Google Scholar
• Kovacs, M., Rush, A. J., Beck, A. T. & Hollon, S. D. Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Arch. Gen. Psychiatry 38, 33–39 (1981).References 35 and 36 show that brief, structured psychotherapies are effective in the treatment of depression, and that they can be successfully combined with pharmacological treatments.
  CAS PubMed Google Scholar
• Nobel Foundation. Nobel Lectures — Physiology or Medicine, 1901–1970 (Elsevier, Amsterdam, 1970).
• Bunney, W. E. & Davis, J. M. Noradrenaline in depressive reactions. A review. Arch. Gen. Psychiatry 13, 483– 494 (1965).
  CAS PubMed Google Scholar
• Schildkraut, J. J., Gordon, E. K. & Durell, J. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine . J. Psychiatr. Res. 3, 213– 228 (1965).
  CAS PubMed Google Scholar
• Coppen, A. The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237–1264 (1967).
  CAS PubMed Google Scholar
• Delgado, P. L. et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry 47, 411 –418 (1990).
  CAS PubMed Google Scholar
• Miller, H. L. et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch. Gen. Psychiatry 53, 117–128 ( 1996).
  CAS PubMed Google Scholar
• Charney, D. S. Monoamine dysfunction and the pathophysiology and treatment of depression . J. Clin. Psychiatry 59, 11– 14 (1998).References 41 – 43 show that noradrenaline- and serotonin-selective probes can potentially identify subsets of depressed patients who might respond differentially to selective noradrenaline or serotonin reuptake inhibitors.
  CAS PubMed Google Scholar
• Thase, M. E., Frank, E. & Kupfer, D. J. in Handbook of Depression: Treatment, Assessment, and Research (eds Beckham, E. E. & Leber, W. R.) 816–913 (Dorsey, Homewood, Illinois, 1985).
  Google Scholar
• Veith, R. C. et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma noradrenaline kinetics. Arch. Gen. Psychiatry 51, 411–422 (1994).
  CAS PubMed Google Scholar
• Wong, M. L. et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl Acad. Sci. USA 97, 325–330 ( 2000).References 45 and 46 report increased activity of sympathetic systems in depression.
  CAS PubMed Google Scholar
• Siever, L. J. & Davis, K. L. Overview: toward a dysregulation hypothesis of depression. Am. J. Psychiatry 142, 1017–1031 (1985).
  CAS PubMed Google Scholar
• Johnstone, E. C. et al. Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol. Med. 10, 321– 328 (1980).
  CAS PubMed Google Scholar
• Sachar, E. J., Hellman, L., Fukushima, D. K. & Gallagher, T. F. Cortisol production in depressive illness: a clinical and biochemical clarification . Arch. Gen. Psychiatry 23, 289– 298 (1970).
  CAS PubMed Google Scholar
• Spiess, J., Rivier, J., Rivier, C. & Vale, W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl Acad. Sci. USA 78, 6517–6521 (1981).
  CAS PubMed Google Scholar
• Gold, P. W. et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiatry 141 , 619–627 (1984).
  CAS PubMed Google Scholar
• Nemeroff, C. B. et al. Elevated concentrations of CSF corticotropin-releasing-factor-like immunoreactivity in depressed patients. Science 226 , 1342–1344 (1984).
  CAS PubMed Google Scholar
• Holsboer, F., Girken, A., Stalia, G. K. & Muller, O. A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N. Engl. J. Med. 311, 1127 (1984).
  CAS PubMed Google Scholar
• Gold, P. W. et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications . N. Engl. J. Med. 314, 1329– 1335 (1986).
  CAS PubMed Google Scholar
• Gold, P. W., Wong, M. L., Chrousos, G. P. & Licinio, J. Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. Mol. Psychiatry 1, 257–264 ( 1996).
  CAS PubMed Google Scholar
• Demitrack, M. A. et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73, 1224–1234 ( 1991).
  CAS PubMed Google Scholar
• Whybrow, P. C. & Prange, A. J. Jr., A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch. Gen. Psychiatry 38, 106–113 (1981).
  CAS PubMed Google Scholar
• Gold, P. W. & Chrousos, G. P. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences . Proc. Assoc. Am. Physicians 111, 22– 34 (1999).
  CAS PubMed Google Scholar
• Whybrow, P. C., Coppen, A., Prange, A. J. Jr, Noguera, R. & Bailey, J. E. Thyroid function and the response to liothyronine in depression. Arch. Gen. Psychiatry 26, 242–245 ( 1972).
  CAS PubMed Google Scholar
• Joffe, R. T. Refractory depression: treatment strategies, with particular reference to the thyroid axis. J. Psychiatry Neurosci. 22, 327–331 (1997).
  CAS PubMed PubMed Central Google Scholar
• Kramer, M. S. et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 1640–1645 (1998).
  CAS PubMed Google Scholar
• Zobel, A. W. et al. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated . J. Psychiatr. Res. 34, 171– 181 (2000).
  CAS PubMed Google Scholar
• Kupfer, D. J., Shaw, D. H., Ulrich, R., Coble, P. A. & Spiker, D. G. Application of automated REM analysis in depression . Arch. Gen. Psychiatry 39, 569– 573 (1982).Documents decreased latency to rapid-eye-movement–sleep onset in depressed patients.
  CAS PubMed Google Scholar
• Gerner, R. H., Post, R. M., Gillin, J. C. & Bunney, W. E. Jr Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals. J. Psychiatr. Res. 15, 21–40 (1979).
  CAS PubMed Google Scholar
• Lipkin, W. I., Travis, G. H., Carbone, K. M. & Wilson, M. C. Isolation and characterization of Borna disease agent cDNA clones. Proc. Natl. Acad. Sci. USA 87, 4184– 4188 (1990).
  CAS PubMed Google Scholar
• Rott, R. et al. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755–756 (1985).
  CAS PubMed Google Scholar
• Bode, L., Zimmermann, W., Ferszt, R., Steinbach, F. & Ludwig, H. Borna disease virus genome transcribed and expressed in psychiatric patients. Nature Med. 1, 232–236 (1995).
  CAS PubMed Google Scholar
• Bode, L., Durrwald, R., Rantam, F. A., Ferszt, R. & Ludwig, H. First isolates of infectious human Borna disease virus from patients with mood disorders. Mol. Psychiatry 1, 200–212 ( 1996).
  CAS PubMed Google Scholar
• De La Torre, J. C. et al. Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients. Virology 223, 272–282 ( 1996).
  CAS PubMed Google Scholar
• Kim, Y. K. et al. Failure to demonstrate Borna disease virus genome in peripheral blood mononuclear cells from psychiatric patients in Korea. J. Neurovirol. 5, 196–199 ( 1999).
  CAS PubMed Google Scholar
• Tsuji, K., Toyomasu, K., Imamura, Y., Maeda, H. & Toyoda, T. No association of borna disease virus with psychiatric disorders among patients in northern Kyushu, Japan. J. Med. Virol. 61, 336–340 (2000).References 65 – 71 report that Borna-disease virus (BDV) might infect a small, but significant portion of patients with depression; however, these findings have not been fully replicated. A causal relation between depression and BDV is at present unclear.
  CAS PubMed Google Scholar
• Solomon, G. F. Psychoneuroimmunology: interactions between central nervous system and immune system. J. Neurosci. Res. 18, 1– 9 (1987).
  CAS PubMed Google Scholar
• Sternberg, E. M. Emotions and disease: from balance of humors to balance of molecules. Nature Med. 3, 264–267 ( 1997).
  CAS PubMed Google Scholar
• Licinio, J., Wong, M. L. & Gold, P. W. Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology 129, 562– 564 (1991).
  CAS PubMed Google Scholar
• Rothwell, N. J. & Hopkins, S. J. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci. 18, 130–136 ( 1995).
  CAS PubMed Google Scholar
• Van Wagoner, N. J. & Benveniste, E. N. Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100, 124–139 (1999).
  CAS PubMed Google Scholar
• Rothwell, N. J. & Luheshi, G. N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618–625 ( 2000).
  CAS PubMed Google Scholar
• Connor, T. J. & Leonard, B. E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 62, 583–606 ( 1998).
  CAS PubMed Google Scholar
• Weiss, J. M., Sundar, S. K., Becker, K. J. & Cierpial, M. A. Behavioral and neural influences on cellular immune responses: effects of stress and interleukin-1. J. Clin. Psychiatry 50, S43–S53 (1989).
  Google Scholar
• Buckingham, J. C., Loxley, H. D., Taylor, A. D. & Flower, R. J. Cytokines, glucocorticoids and neuroendocrine function. Pharmacol. Res. 30, 35–42 ( 1994).
  CAS PubMed Google Scholar
• Rivier, C. Effect of peripheral and central cytokines on the hypothalamic–pituitary–adrenal axis of the rat. Ann. NY Acad. Sci. 697, 97–105 (1993).
  CAS PubMed Google Scholar
• Ramamoorthy, S. et al. Regulation of the human serotonin transporter by interleukin-1β . Biochem. Biophys. Res. Commun. 216, 560 –567 (1995).
  CAS PubMed Google Scholar
• Maes, M. et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853–858 ( 1997).
  CAS PubMed Google Scholar
• Wong, M. L., Bongiorno, P. B., Rettori, V., McCann, S. M. & Licinio, J. Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications . Proc. Natl Acad. Sci. USA 94, 227– 232 (1997).Shows that central and peripheral cytokine compartments are integrated but differentially regulated: central cytokines are counter-regulated to a smaller extent than peripherally secreted ones.
  CAS PubMed Google Scholar
• Licinio, J. & Wong, M. L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4, 317–327 (1999).
  CAS PubMed Google Scholar
• Lander, E. S. & Schork, N. J. Genetic dissection of complex traits. Science 265, 2037– 2048 (1994).
  CAS PubMed Google Scholar
• Fava, M. & Kendler, K. S. Major depressive disorder. Neuron 28, 335–341 ( 2000).
  CAS PubMed Google Scholar
• Sullivan, P. F., Neale, M. C. & Kendler, K. S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157, 1552–1562 (2000). Shows that depression is caused by both genetic and environmental factors.
  CAS Google Scholar
• Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C. & Eaves, L. J. The lifetime history of major depression in women. Reliability of diagnosis and heritability. Arch. Gen. Psychiatry 50, 863–870 ( 1993).Shows that major depression as assessed over one's lifetime might be a rather highly heritable disorder of moderate reliability rather than a moderately heritable disorder of high reliability.
  CAS PubMed Google Scholar
• Lesch, K. P. et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531 (1996). Discovery of a polymorphism in the regulatory region of the serotonin transporter gene that reduces transcriptional efficiency and might be correlated with anxiety traits.
  CAS PubMed Google Scholar
• Smeraldi, E. et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry 3, 508–511 ( 1998).Proposes that genotyping the serotonin transporter regulatory region might be used as a tool to predict treatment response in depression.
  CAS PubMed Google Scholar
• Kim, D. K. et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11, 215– 219 (2000).
  CAS PubMed Google Scholar
• Benedetti, F. et al. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am. J. Psychiatry 156, 1450–1452 (1999).
  CAS PubMed Google Scholar
• Wong, M. L., Khatri, P., Licinio, J., Esposito, A. & Gold, P. W. Identification of hypothalamic transcripts upregulated by antidepressants. Biochem. Biophys. Res. Commun. 229, 275–279 (1996).
  CAS PubMed Google Scholar
• Hyman, S. E. Mental illness. Genetically complex disorders of neural circuitry and neural communication. Neuron 28, 321– 323 (2000). PubMedReviews the complexity of depression genetics.
  CAS PubMed Google Scholar
• Selye, H. A syndrome produced by diverse nocuous agents. Nature 138, 32 (1936).In this one-page article, Selye launched the field of stress biology. He showed that the organism had common responses to various types of stressor, and described those responses as much as it was possible using the methods available to him in the 1930s.
  Google Scholar
• Chrousos, G. P. & Gold, P. W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis . JAMA 267, 1244–1252 (1992).
  CAS PubMed Google Scholar
• Brady, L. S., Whitfield, H. J. Jr, Fox, R. J., Gold, P. W. & Herkenham, M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications . J. Clin. Invest. 87, 831– 837 (1991).
  CAS PubMed PubMed Central Google Scholar
• Brady, L. S., Gold, P. W., Herkenham, M., Lynn, A. B. & Whitfield, H. J. Jr The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications . Brain Res. 572, 117–125 (1992).
  CAS Google Scholar
• Michelson, D. et al. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. J. Clin. Endocrinol. Metab. 82, 2601–2606 ( 1997).References 98 – 100 show that attenuation of hypothalamus–pituitary–adrenal axis activity is a direct pharmacological effect of antidepressants.
  CAS PubMed Google Scholar
• Habib, K. E. et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl Acad. Sci. USA 97, 6079–6084 (2000).
  CAS PubMed Google Scholar